Diabetes: Google gets into medtech with plans for glucose-measuring contact lens
Ivantis rakes in $46.5M and advances U.S. trial for glaucoma device
Opthalmic devices maker Ivantis padded its Series B funding round with another $14 million raised, bringing the total to $46.5 million.
The funds are slated to help Ivantis through 3 large clinical trials and may be enough to get the company through U.S. approval for its Hydrus Microstent glaucoma treatment device.
Ocular Therapeutix lands FDA approval for ReSure sealant
Massachusetts medical device maker Ocular Therapeutix announced today that it won FDA premarket approval for its flagship ReSure sealant, a hydrogel designed to help heal surgical wounds in the eye.
LensAR closes $10M equity funding round
Orlando, Fla.-based cataract surgery technology company LensAR closed an equity funding round with $10 million raised from 14 investors, regulatory documents show.
The fundraising effort, launched in December, was closed yesterday and use of the proceeds was not described, outside of an estimated $370,000 listed in payments to individuals listed as "executive officers, directors or promoters" of the company.
Carl Zeiss expands lens portfolio with $70M Aaren Scientific buy
Optical lenses maker Carl Zeiss Meditec (ETR:AFX) paid $70 million to acquire 100% of the assets of intraocular lens manufacturer Aaren Scientific, the companies announced this week.
Solx adds $2M in options round
Solx said it added $2.1 million to its coffers in an options and debt round.
The Waltham, Mass.-based medical device company is seeking around $4.8 million in funding. The $2.1 million so far has come from 3 unnamed investors, according to a regulatory filing.